Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Thomas

Showing results (681-690 of 726) with videos related to

Pageof 73
Sort By:
Translational Lung Cancer Research|May 20, 2021
Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinomaDaniel Kazdal, Eugen Rempel, Cristiano Oliveira, et al.
The Lancet. Oncology|June 12, 2021
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 studyJustin F Gainor, Giuseppe Curigliano, Dong-Wan Kim, et al.
Oncology|May 21, 2026
Decision making in intrathecal therapy for leptomeningeal diseaseSusanne Weindler, Thomas Hundsberger, Alfredo Addeo, et al.
Health Technology Assessment (Winchester, England)|July 12, 2023
Antibiotics for lower respiratory tract infection in children presenting in primary care: ARTIC-PC RCTPaul Little, Nick A Francis, Beth Stuart, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 27, 2019
Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical ArtifactsDaniel Kazdal, Volker Endris, Michael Allgäuer, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2015
Dihydropyrrolopyrazol-6-one MCHR1 antagonists for the treatment of obesity: Insights on in vivo efficacy from a novel FLIPR assay setupPratik Devasthale, Wei Wang, Andres S Hernandez, et al.
Lancet (London, England)|September 25, 2021
Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trialPaul Little, Nick A Francis, Beth Stuart, et al.
Molecular Cancer|May 9, 2024
Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cellsLisa-Marie Rieckmann, Michael Spohn, Lisa Ruff, et al.
NPJ Precision Oncology|April 1, 2022
A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapyTimothy Rajakumar, Rastislav Horos, Julia Jehn, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2015
Non-basic azolotriazinone MCHR1 antagonists for the treatment of obesity: An empirical brain-exposures-driven candidate selection for in vivo efficacy studiesPratik Devasthale, Wei Wang, James Mignone, et al.
Pageof 73

Showing results (681-690 of 726) with videos related to

Sort By:
Pageof 73
Translational Lung Cancer Research|May 20, 2021
Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinomaDaniel Kazdal, Eugen Rempel, Cristiano Oliveira, et al.
The Lancet. Oncology|June 12, 2021
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 studyJustin F Gainor, Giuseppe Curigliano, Dong-Wan Kim, et al.
Oncology|May 21, 2026
Decision making in intrathecal therapy for leptomeningeal diseaseSusanne Weindler, Thomas Hundsberger, Alfredo Addeo, et al.
Health Technology Assessment (Winchester, England)|July 12, 2023
Antibiotics for lower respiratory tract infection in children presenting in primary care: ARTIC-PC RCTPaul Little, Nick A Francis, Beth Stuart, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 27, 2019
Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical ArtifactsDaniel Kazdal, Volker Endris, Michael Allgäuer, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2015
Dihydropyrrolopyrazol-6-one MCHR1 antagonists for the treatment of obesity: Insights on in vivo efficacy from a novel FLIPR assay setupPratik Devasthale, Wei Wang, Andres S Hernandez, et al.
Lancet (London, England)|September 25, 2021
Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trialPaul Little, Nick A Francis, Beth Stuart, et al.
Molecular Cancer|May 9, 2024
Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cellsLisa-Marie Rieckmann, Michael Spohn, Lisa Ruff, et al.
NPJ Precision Oncology|April 1, 2022
A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapyTimothy Rajakumar, Rastislav Horos, Julia Jehn, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2015
Non-basic azolotriazinone MCHR1 antagonists for the treatment of obesity: An empirical brain-exposures-driven candidate selection for in vivo efficacy studiesPratik Devasthale, Wei Wang, James Mignone, et al.
Pageof 73